How to analyze the company?LEARNWhat should you know before buying?
Get a brief AI stock analysisSaves ~ 15 minutes of your time

AG

NYSE-MKT:AGE
Get a brief AI stock analysisSaves ~ 15 minutes of your time

AG

AgeX Therapeutics IncNYSE-MKT AGE Stock Report

Get a brief AI stock analysis
Saves ~ 15 minutes of your time

Price

Market cap $B

Exchange

XASE - Nyse MKT LLC

FAIR VALUE

Is AGE undervalued compared to its fair value?

The fair value of AGE stock is hidden USD. Relative to the market price of 8.84 USD AgeX Therapeutics Inc is hidden.

AgeX Therapeutics, Inc. operates as a biotechnology company, which engages in the development and commercialization of novel therapeutics targeting human aging and degenerative diseases. The company is headquartered in A...[More about valuation]

AgeX Therapeutics Fair Value

hidden
UNLOCK
What is fair value?

Market cap:

0.028 $B

Price:

8.84 USD

Fair value:

hidden

Max value:

hidden

Min value:

hidden

P/E:

hidden

EPS:

-0.142

FINANCIALS

AgeX Therapeutics financial for reporting period

Income Statement

0.0001 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.0024 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.0054 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
Revenue analysis

0.0001 B 100%
-0.0024 B -3371%
-0.0054 B -7714%

Balance Sheet

0.012 B
0.0084 B

0.0022 B

Financial Position Analysis

Assets

0.012 B
Current Assets
0.0011 B
Total non-current assets
0.011 B

Total current liabilities
0.0032 B
Total non-current liabilities
0.0006 B

Cash Flow Statement

0.0001 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.0019 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

AgeX Therapeutics fundamental analysis for trailing twelve months (TTM)

Profitability Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Solvency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Efficiency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%
-107 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%
-140 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Dupont Analysis

Stability Indicators

STOCK ANALYSIS

Is AGE attractive for investment based on fundamental analysis?

AGE stock rating is hidden. AgeX Therapeutics is a hidden by Eyestock methodology.

Get AGE Stock Rating
to complete you analysis
UNLOCK
Learn more about quality score?

Net Profit Margin:

-14 050

Gross Margin:

50

CFO / Debt ratio:

hidden

Current ratio:

0.111

Debt / Equity ratio:

ROE:

ROIC:

hidden

Stability Ratio (2y):

hidden

Stability Ratio (5y):

hidden

Earnings quality:

hidden

AGE analysis by AI

Eyebot AI analysis

We carefully consider 10 indicators for AGE to calculate the final rating score. Use AI leverage to quickly get the main conclusions before diving into the details

AgeX Therapeutics Inc competitors

AB

ABBV

Abbvie Inc

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. The company is headquartered in North Chicago, Ill...

Discover

AM

AMGN

Amgen Inc

Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It operates in human therapeutics segment. The Company...

Discover

VR

VRTX

Vertex Pharmaceuticals Inc

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs fo...

Discover

AgeX Therapeutics Inc dividends

AGE dividend metrics

Payout ratio
Dividend yield
Annual dividend
Dividend streak
Average dividend yield over 3 years
Average dividend yield over 5 years

Dividend per share

By years
By payments
1y
3y
5y
All time
This ticker has no dividend history

About AGE stock

About the company AgeX Therapeutics Inc

Market cap $B

0.028

Dividend yield

Shares outstanding

37.9472 B

AgeX Therapeutics, Inc. operates as a biotechnology company, which engages in the development and commercialization of novel therapeutics targeting human aging and degenerative diseases. The company is headquartered in Alameda, California and currently employs 5 full-time employees. The company went IPO on 2018-11-29. The firm's product pipeline includes two cell-based therapies, which is derived from telomerase-positive pluripotent stem cells (PSCs) and two product candidates, which is derived from its induced Tissue Regeneration (iTRTM) technology. The firm's AGEX-BAT1 is being developed for the treatment of certain age-related metabolic disorders, such as Type II (adult-onset) diabetes. Its AGEX-VASC1 is designed to restore vascular support in aged ischemic tissues, such as the aging heart. The firm's iTRTM technology product candidates include AGEX-iTR1547, which is a drug-based formulation, and AGEX-iTR1550 (Renelon), which is a gene delivery technology.

AGE profile

  • Ticker

    AGE

  • Country

    USA

  • Exchange

    XASE - Nyse MKT LLC

  • Report currency

    USD - US dollar

  • IPO date

    29 November 2018

  • Sector

    Healthсare

  • Industry

    Biotechnology

  • Employees

    5

  • City

    Alameda

  • Address

    1101 Marina Village Parkway, Suite 201

  • Cusip

    00848H108